ArticleJAMA oncology2021

Should Thiotepa-Based Regimens Be the New Transplant Conditioning Strategy for Primary Central Nervous System Lymphoma?

John M Hill et al.PubMed ↗Publisher ↗

No numbers read from the abstract.